Counterpath (CPAH) Tops Q1 Views

September 14, 2016 8:18 AM EDT
Get Alerts CPAH Hot Sheet
Trade CPAH Now!
Join SI Premium – FREE

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

Counterpath (NASDAQ: CPAH) reported Q1 EPS of ($0.01), $0.16 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $3 million versus the consensus estimate of $2.6 million.

For earnings history and earnings-related data on Counterpath (CPAH) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment